Lu L, Leonard C, Thompson P, Kan E, Jolley J, Welcome SE et al (2007)
Recently, Ozempic was approved by the U.S
The 1.0 mg to 1.7 mg and 1.7 mg to 2.4 mg transitions are smaller relative increases, but cumulative GI adaptation means they usually feel less dramatic than earlier escalations
Important safety considerations include: Acute pancreatitis : Treatment should be discontinued if pancreatitis is suspected and not restarted if confirmed Gallbladder disease : Risk of cholelithiasis and cholecystitis is increased [13] [27] Diabetic retinopathy : Monitoring is recommended in people with pre-existing retinopathy Hypoglycaemia : Risk increases when used with insulin or sulfonylureas
Ozempic Black Box Warning The original Ozempic label included a black box warning against use by individuals with personal or family histories of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)
When should I call the office or seek urgent care